Piperazine PDE4 inhibitors and uses thereof
US8501745B2 · kind B2 · utility
0Cited by
9References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2010 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | Oct 21, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention includes a compound of formula I:wherein R1, X, Z, n, and m have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of PDE4 function and are useful for improving cognitive function in animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.